{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:28:20Z","timestamp":1793899700492,"version":"4.8.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/002672"],"award-info":[{"award-number":["CRG\/2022\/002672"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00044-026-03621-7","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:55:25Z","timestamp":1790229325000},"page":"2283-2299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing antifolates as G9a methyltransferase inhibitors for potential Alzheimer\u2019s disease therapeutics via 3D QSAR\/pharmacophore mapping and experimental validations"],"prefix":"10.1007","volume":"35","author":[{"given":"Abhisek","family":"Jana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Bellver-Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushik","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gri\u00f1\u00e1n-Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2058-896X","authenticated-orcid":false,"given":"Deb Ranjan","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"3621_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1126\/science.293.5532.1103","volume":"293","author":"C-t Wu","year":"2001","unstructured":"Wu C-t, Morris JR. Genes, Genetics, and Epigenetics: A Correspondence. Sci (1979). 2001;293:1103\u20135. https:\/\/doi.org\/10.1126\/science.293.5532.1103.","journal-title":"Sci (1979)"},{"key":"3621_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0029-1237423","volume":"27","author":"C Dupont","year":"2009","unstructured":"Dupont C, Armant D, Brenner C. Epigenetics: Definition, Mechanisms and Clinical Perspective. Semin Reprod Med. 2009;27:351\u20137. https:\/\/doi.org\/10.1055\/s-0029-1237423.","journal-title":"Semin Reprod Med"},{"key":"3621_CR3","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1021\/cr500350x","volume":"115","author":"GD Bowman","year":"2015","unstructured":"Bowman GD, Poirier MG. Post-Translational Modifications of Histones That Influence Nucleosome Dynamics. Chem Rev. 2015;115:2274\u201395. https:\/\/doi.org\/10.1021\/cr500350x.","journal-title":"Chem Rev"},{"key":"3621_CR4","doi-asserted-by":"publisher","first-page":"18329","DOI":"10.1021\/jacs.2c06156","volume":"144","author":"H Ai","year":"2022","unstructured":"Ai H, Chu G-C, Gong Q, et al. Chemical Synthesis of Post-Translationally Modified H2AX Reveals Redundancy in Interplay between Histone Phosphorylation, Ubiquitination, and Methylation on the Binding of 53BP1 with Nucleosomes. J Am Chem Soc. 2022;144:18329\u201337. https:\/\/doi.org\/10.1021\/jacs.2c06156.","journal-title":"J Am Chem Soc"},{"key":"3621_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/cb500785t","volume":"10","author":"H\u00dc Kaniskan","year":"2015","unstructured":"Kaniskan H\u00dc, Jin J. Chemical Probes of Histone Lysine Methyltransferases. ACS Chem Biol. 2015;10:40\u201350. https:\/\/doi.org\/10.1021\/cb500785t.","journal-title":"ACS Chem Biol"},{"key":"3621_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/35020506","volume":"406","author":"S Rea","year":"2000","unstructured":"Rea S, Eisenhaber F, O\u2019Carroll D, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000;406:593\u20139. https:\/\/doi.org\/10.1038\/35020506.","journal-title":"Nature"},{"key":"3621_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1101\/gad.989402","volume":"16","author":"M Tachibana","year":"2002","unstructured":"Tachibana M, Sugimoto K, Nozaki M, et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002;16:1779\u201391. https:\/\/doi.org\/10.1101\/gad.989402.","journal-title":"Genes Dev"},{"key":"3621_CR8","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1073\/pnas.1014660108","volume":"108","author":"DC Leung","year":"2011","unstructured":"Leung DC, Dong KB, Maksakova IA, et al. Lysine methyltransferase G9a is required for de novo DNA methylation and the establishment, but not the maintenance, of proviral silencing. Proc Natl Acad Sci. 2011;108:5718\u201323. https:\/\/doi.org\/10.1073\/pnas.1014660108.","journal-title":"Proc Natl Acad Sci"},{"key":"3621_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","volume":"18","author":"J Ding","year":"2013","unstructured":"Ding J, Li T, Wang X, et al. The Histone H3 Methyltransferase G9A Epigenetically Activates the Serine-Glycine Synthesis Pathway to Sustain Cancer Cell Survival and Proliferation. Cell Metab. 2013;18:896\u2013907. https:\/\/doi.org\/10.1016\/j.cmet.2013.11.004.","journal-title":"Cell Metab"},{"key":"3621_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1021\/ml400496h","volume":"5","author":"RF Sweis","year":"2014","unstructured":"Sweis RF, Pliushchev M, Brown PJ, et al. Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a. ACS Med Chem Lett. 2014;5:205\u20139. https:\/\/doi.org\/10.1021\/ml400496h.","journal-title":"ACS Med Chem Lett"},{"key":"3621_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.14336\/AD.2023.0424-2","volume":"15","author":"A Bellver-Sanchis","year":"2024","unstructured":"Bellver-Sanchis A, Geng Q, Navarro G, et al. G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer\u2019s Disease. Aging Dis. 2024;15:311. https:\/\/doi.org\/10.14336\/AD.2023.0424-2.","journal-title":"Aging Dis"},{"key":"3621_CR12","doi-asserted-by":"publisher","first-page":"e202200002","DOI":"10.1002\/cmdc.202200002","volume":"17","author":"A Bellver-Sanchis","year":"2022","unstructured":"Bellver-Sanchis A, Singh Choudhary B, Companys-Alemany J, et al. Structure-Based Virtual Screening and in\u2005vitro and in\u2005vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti-Alzheimer\u2019s Agents. ChemMedChem. 2022;17:e202200002. https:\/\/doi.org\/10.1002\/cmdc.202200002.","journal-title":"ChemMedChem"},{"key":"3621_CR13","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.3c00344","author":"A Jana","year":"2023","unstructured":"Jana A, Bellver-Sanchis A, Gri\u00f1\u00e1n-Ferr\u00e9 C, Banerjee DR. Repurposing of Raltitrexed as an Effective G9a\/EHMT2 Inhibitor and Promising Anti-Alzheimer\u2019s Agent. ACS Med Chem Lett. 2023. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00344.","journal-title":"ACS Med Chem Lett"},{"key":"3621_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/med.22096","volume":"45","author":"A Bellver-Sanchis","year":"2025","unstructured":"Bellver-Sanchis A, Ribalta\u2010Vilella M, Irisarri A, et al. G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials. Med Res Rev. 2025;45:985\u20131015. https:\/\/doi.org\/10.1002\/med.22096.","journal-title":"Med Res Rev"},{"key":"3621_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.14336\/AD.2023.0424-2","volume":"15","author":"A Bellver-Sanchis","year":"2024","unstructured":"Bellver-Sanchis A, Geng Q, Navarro G, et al. G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer\u2019s Disease. Aging Dis. 2024;15:311\u201337. https:\/\/doi.org\/10.14336\/AD.2023.0424-2.","journal-title":"Aging Dis"},{"key":"3621_CR16","doi-asserted-by":"publisher","first-page":"11591","DOI":"10.18632\/aging.102558","volume":"11","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2019","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, Marsal-Garc\u00eda L, Bellver-Sanchis A, et al. Pharmacological inhibition of G9a\/GLP restores cognition and reduces oxidative stress, neuroinflammation and \u03b2-Amyloid plaques in an early-onset Alzheimer\u2019s disease mouse model. Aging. 2019;11:11591\u2013608. https:\/\/doi.org\/10.18632\/aging.102558.","journal-title":"Aging"},{"key":"3621_CR17","doi-asserted-by":"publisher","unstructured":"Nemr MTM, Fadaly WAA, Abdelaziz MA. Pharmaceutical Applications of Di\/Tri-Aryl Pyrazole Derivatives: A Review on Recent Updates. ChemistrySelect. 2025;10. https:\/\/doi.org\/10.1002\/slct.202504601.","DOI":"10.1002\/slct.202504601"},{"key":"3621_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.biochi.2026.02.015","volume":"245","author":"G Antoniolli","year":"2026","unstructured":"Antoniolli G, Nemr MTM, Marques SPD, et al. Discovery of 6,7-dimethoxyquinazoline-hydrazide hybrids as dual inhibitors of acetylcholinesterase and \u03b2-secretase. Biochimie. 2026;245:88\u201398. https:\/\/doi.org\/10.1016\/j.biochi.2026.02.015.","journal-title":"Biochimie"},{"key":"3621_CR19","doi-asserted-by":"publisher","unstructured":"Nemr MTM, Mohamed LW, Sayed HS, Mikhail DS. Design, Synthesis, In Vitro and In Vivo Biological Evaluation of Novel Pyrazolo[3,4- d ]Pyrimidine\u2010Based Derivatives as Promising Multitarget Candidates for Alzheimer\u2019s Disease. Drug Dev Res. 2026;87. https:\/\/doi.org\/10.1002\/ddr.70259.","DOI":"10.1002\/ddr.70259"},{"key":"3621_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/17568919.2025.2594969","volume":"18","author":"MTM Nemr","year":"2026","unstructured":"Nemr MTM, Elshaier YAAM, Ewieda SY, Abdelaziz MA. Pharmaceutical applications of cyclopropyl containing scaffolds: a review on recent updates. Future Med Chem. 2026;18:79\u201388. https:\/\/doi.org\/10.1080\/17568919.2025.2594969.","journal-title":"Future Med Chem"},{"key":"3621_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat Rev Drug Discov"},{"key":"3621_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/bph.16001","volume":"180","author":"Z On\u00f3di","year":"2023","unstructured":"On\u00f3di Z, Koch S, Rubinstein J, et al. Drug repurposing for cardiovascular diseases: New targets and indications for probenecid. Br J Pharmacol. 2023;180:685\u2013700. https:\/\/doi.org\/10.1111\/bph.16001.","journal-title":"Br J Pharmacol"},{"key":"3621_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00280-023-04528-5","volume":"91","author":"J Br\u00e9","year":"2023","unstructured":"Br\u00e9 J, Dickson AL, Read OJ, et al. The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent. Cancer Chemother Pharmacol. 2023;91:401\u201312. https:\/\/doi.org\/10.1007\/s00280-023-04528-5.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3621_CR24","first-page":"2538","volume":"6","author":"SJ Welsh","year":"2000","unstructured":"Welsh SJ, Titley J, Brunton L, et al. Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues. Clin Cancer Res. 2000;6:2538\u201346.","journal-title":"Clin Cancer Res"},{"key":"3621_CR25","doi-asserted-by":"publisher","first-page":"13449","DOI":"10.1074\/jbc.M117.787267","volume":"292","author":"D Chen","year":"2017","unstructured":"Chen D, Jansson A, Sim D, et al. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states. J Biol Chem. 2017;292:13449\u201358. https:\/\/doi.org\/10.1074\/jbc.M117.787267.","journal-title":"J Biol Chem"},{"key":"3621_CR26","doi-asserted-by":"publisher","unstructured":"Phan J, Koli S, Minor W, et al. Human Thymidylate Synthase Is in the Closed Conformation When Complexed with dUMP and Raltitrexed, an Antifolate Drug ,. Biochemistry. 2001;40:1897\u2013902. https:\/\/doi.org\/10.1021\/bi002413i.","DOI":"10.1021\/bi002413i"},{"key":"3621_CR27","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1021\/jm300850v","volume":"55","author":"E Carosati","year":"2012","unstructured":"Carosati E, Tochowicz A, Marverti G, et al. Inhibitor of Ovarian Cancer Cells Growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase. J Med Chem. 2012;55:10272\u20136. https:\/\/doi.org\/10.1021\/jm300850v.","journal-title":"J Med Chem"},{"key":"3621_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2022.2135600","author":"A Jana","year":"2022","unstructured":"Jana A, Naga R, Saha S, Banerjee DR. 3D QSAR pharmacophore based lead identification of G9a lysine methyltransferase towards epigenetic therapeutics. J Biomol Struct Dyn. 2022. https:\/\/doi.org\/10.1080\/07391102.2022.2135600.","journal-title":"J Biomol Struct Dyn"},{"key":"3621_CR29","doi-asserted-by":"crossref","unstructured":"Bellver-Sanchis AGQNG, et al. G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer\u2019s Disease. Aging Dis; 2023.","DOI":"10.14336\/AD.2023.0424-2"},{"key":"3621_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1385\/1-59259-964-8:375","volume-title":"Bioinformatics and Drug Discovery","author":"CG Bologa","year":"2006","unstructured":"Bologa CG, Olah MM, Oprea TI. Chemical Database Preparation for Compound Acquisition or Virtual Screening. In: Larson RS, editor. Bioinformatics and Drug Discovery. Totowa, NJ: Humana; 2006. pp. 375\u201388"},{"key":"3621_CR31","doi-asserted-by":"publisher","unstructured":"Jana A, Naga R, Saha S, et al. Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2\/G9a). J Biomol Struct Dyn. 2023;1\u201328. https:\/\/doi.org\/10.1080\/07391102.2023.2213346.","DOI":"10.1080\/07391102.2023.2213346"},{"key":"3621_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0.","journal-title":"Adv Drug Deliv Rev"},{"key":"3621_CR33","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, et al. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J Med Chem. 2002;45:2615\u201323. https:\/\/doi.org\/10.1021\/jm020017n.","journal-title":"J Med Chem"},{"key":"3621_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1124\/jpet.105.090043","volume":"315","author":"H Dai","year":"2005","unstructured":"Dai H, Chen Y, Elmquist WF. Distribution of the Novel Antifolate Pemetrexed to the Brain. J Pharmacol Exp Ther. 2005;315:222\u20139. https:\/\/doi.org\/10.1124\/jpet.105.090043.","journal-title":"J Pharmacol Exp Ther"},{"key":"3621_CR35","unstructured":"Li, Li. (2010) Active efflux transport and CNS distribution of the novel antifolate pemetrexed. University of Minnesota Ph.D. dissertation."},{"key":"3621_CR36","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/ijc.33721","volume":"149","author":"RJ Boosman","year":"2021","unstructured":"Boosman RJ, Dorlo TPC, de Rouw N, et al. Toxicity of pemetrexed during renal impairment explained\u2014Implications for safe treatment. Int J Cancer. 2021;149:1576\u201384. https:\/\/doi.org\/10.1002\/ijc.33721.","journal-title":"Int J Cancer"},{"key":"3621_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bulcan.2014.12.012","volume":"102","author":"H Izzedine","year":"2015","unstructured":"Izzedine H. N\u00e9phrotoxicit\u00e9 du pemetrexed. Bull Cancer. 2015;102:190\u20137. https:\/\/doi.org\/10.1016\/j.bulcan.2014.12.012.","journal-title":"Bull Cancer"},{"key":"3621_CR38","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1021\/jm901543m","volume":"52","author":"F Liu","year":"2009","unstructured":"Liu F, Chen X, Allali-Hassani A, et al. Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a. J Med Chem. 2009;52:7950\u20133. https:\/\/doi.org\/10.1021\/jm901543m.","journal-title":"J Med Chem"},{"key":"3621_CR39","unstructured":"BIOVIA. (2022), Dassault Syst\u00e8mes, BIOVIA Discovery Studio Academic Research Suite, San Diego:Dassault Syst\u00e8mes."},{"key":"3621_CR40","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.ejmech.2011.03.035","volume":"46","author":"S Thangapandian","year":"2011","unstructured":"Thangapandian S, John S, Sakkiah S, Lee KW. Potential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches. Eur J Med Chem. 2011;46:2469\u201376. https:\/\/doi.org\/10.1016\/j.ejmech.2011.03.035.","journal-title":"Eur J Med Chem"},{"key":"3621_CR41","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-12-S14-S4","volume":"12","author":"S John","year":"2011","unstructured":"John S, Thangapandian S, Arooj M, et al. Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors. BMC Bioinformatics. 2011;12:S4. https:\/\/doi.org\/10.1186\/1471-2105-12-S14-S4.","journal-title":"BMC Bioinformatics"},{"key":"3621_CR42","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1021\/ci800081s","volume":"48","author":"J Koska","year":"2008","unstructured":"Koska J, Spassov VZ, Maynard AJ, et al. Fully Automated Molecular Mechanics Based Induced Fit Protein\u2013Ligand Docking Method. J Chem Inf Model. 2008;48:1965\u201373. https:\/\/doi.org\/10.1021\/ci800081s.","journal-title":"J Chem Inf Model"},{"key":"3621_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1110\/ps.062447107","volume":"16","author":"VZ Spassov","year":"2007","unstructured":"Spassov VZ, Yan L, Flook PK. The dominant role of side-chain backbone interactions in structural realization of amino acid code. ChiRotor: A side-chain prediction algorithm based on side-chain backbone interactions. Protein Sci. 2007;16:494\u2013506. https:\/\/doi.org\/10.1110\/ps.062447107.","journal-title":"Protein Sci"},{"key":"3621_CR44","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow DE, Xu H et al. (2006) Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. In: ACM\/IEEE SC 2006 Conference (SC\u201906). IEEE, pp 43\u201343.","DOI":"10.1109\/SC.2006.54"},{"key":"3621_CR45","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926\u201335. https:\/\/doi.org\/10.1063\/1.445869.","journal-title":"J Chem Phys"},{"key":"3621_CR46","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J Am Chem Soc. 1996;118:11225\u201336. https:\/\/doi.org\/10.1021\/ja9621760.","journal-title":"J Am Chem Soc"},{"key":"3621_CR47","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1021\/j100078a035","volume":"98","author":"DD Humphreys","year":"1994","unstructured":"Humphreys DD, Friesner RA, Berne BJ. A Multiple-Time-Step Molecular Dynamics Algorithm for Macromolecules. J Phys Chem. 1994;98:6885\u201392. https:\/\/doi.org\/10.1021\/j100078a035.","journal-title":"J Phys Chem"},{"key":"3621_CR48","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, et al. A smooth particle mesh Ewald method. J Chem Phys. 1995;103:8577\u201393. https:\/\/doi.org\/10.1063\/1.470117.","journal-title":"J Chem Phys"},{"key":"3621_CR49","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover WG. Canonical dynamics: Equilibrium phase-space distributions. Phys Rev (Coll Park). 1985;31:1695\u20137. https:\/\/doi.org\/10.1103\/PhysRevA.31.1695.","journal-title":"Phys Rev (Coll Park)"},{"key":"3621_CR50","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna GJ, Tobias DJ, Klein ML. Constant pressure molecular dynamics algorithms. J Chem Phys. 1994;101:4177\u201389. https:\/\/doi.org\/10.1063\/1.467468.","journal-title":"J Chem Phys"},{"key":"3621_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449\u201361. https:\/\/doi.org\/10.1517\/17460441.2015.1032936.","journal-title":"Expert Opin Drug Discov"},{"key":"3621_CR52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1142\/S273741652550019X","volume":"24","author":"A Jana","year":"2025","unstructured":"Jana A, Mabhai S, Raja S, et al. Uncovering New Hits against Lysine Demethylase (LSD1) using Dual 3D Pharmacophores and Multi-Tier Rational Screening. J Comput Biophys Chem. 2025;24:1245\u201363. https:\/\/doi.org\/10.1142\/S273741652550019X.","journal-title":"J Comput Biophys Chem"},{"key":"3621_CR53","doi-asserted-by":"publisher","first-page":"9368","DOI":"10.1073\/pnas.92.20.9368","volume":"92","author":"CD Link","year":"1995","unstructured":"Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1995;92:9368\u201372. https:\/\/doi.org\/10.1073\/pnas.92.20.9368.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03621-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:05:20Z","timestamp":1793898320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03621-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3621"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03621-7","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"7 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}